[go: up one dir, main page]

WO1999018131A3 - Anti-bip-antikörper bei rheumatoider arthritis sowie verfahren und testkits zu ihrer bestimmung - Google Patents

Anti-bip-antikörper bei rheumatoider arthritis sowie verfahren und testkits zu ihrer bestimmung Download PDF

Info

Publication number
WO1999018131A3
WO1999018131A3 PCT/DE1998/002942 DE9802942W WO9918131A3 WO 1999018131 A3 WO1999018131 A3 WO 1999018131A3 DE 9802942 W DE9802942 W DE 9802942W WO 9918131 A3 WO9918131 A3 WO 9918131A3
Authority
WO
WIPO (PCT)
Prior art keywords
antibodies
rheumatoid arthritis
bip
detecting
test kits
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DE1998/002942
Other languages
English (en)
French (fr)
Other versions
WO1999018131A2 (de
Inventor
Stefan Blaess
Gerd-R Burmester
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to EP98958806A priority Critical patent/EP1019441A2/de
Priority to JP2000514938A priority patent/JP2001519357A/ja
Publication of WO1999018131A2 publication Critical patent/WO1999018131A2/de
Publication of WO1999018131A3 publication Critical patent/WO1999018131A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Die Erfindung betrifft Anti-Heavy Chain Binding Protein-Antikörper (Anti-BiP-Antikörper) in Körperflüssigkeiten von Patienten mit rheumatoider Arthritis sowie den Nachweis von Anti-BiP-Antikörpern. Sie bezieht sich insbesondere auf den Nachweis dieser Antikörper als Autoantikörper für die serologische Diagnostik einer rheumatoiden Arthritis in Differentialdiagnose zu anderen Erkrankungen des rheumatischen Formenkreises in vitro.
PCT/DE1998/002942 1997-10-01 1998-09-30 Anti-bip-antikörper bei rheumatoider arthritis sowie verfahren und testkits zu ihrer bestimmung Ceased WO1999018131A2 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP98958806A EP1019441A2 (de) 1997-10-01 1998-09-30 Anti-bip-antikörper bei rheumatoider arthritis sowie verfahren und testkits zu ihrer bestimmung
JP2000514938A JP2001519357A (ja) 1997-10-01 1998-09-30 慢性関節リウマチにおける抗ＢｉＰ抗体並びにそれらの検出のための方法及び試験キット

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1997144132 DE19744132A1 (de) 1997-10-01 1997-10-01 Anti-Heavy Chain Binding Protein-Antikörper (Anti-BiP-Antikörper) bei rheumatoider Arthritis sowie Verfahren und Testkits zu ihrer Bestimmung in Körperflüssigkeiten
DE19744132.7 1997-10-01

Publications (2)

Publication Number Publication Date
WO1999018131A2 WO1999018131A2 (de) 1999-04-15
WO1999018131A3 true WO1999018131A3 (de) 1999-06-17

Family

ID=7844757

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1998/002942 Ceased WO1999018131A2 (de) 1997-10-01 1998-09-30 Anti-bip-antikörper bei rheumatoider arthritis sowie verfahren und testkits zu ihrer bestimmung

Country Status (4)

Country Link
EP (1) EP1019441A2 (de)
JP (1) JP2001519357A (de)
DE (1) DE19744132A1 (de)
WO (1) WO1999018131A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9822115D0 (en) 1998-10-09 1998-12-02 King S College London Treatment of inflammatory disease
DE10115083A1 (de) * 2001-03-27 2002-10-10 Schebo Biotech Ag Nachweis von Milchdrüsenentzündungen

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CONROY S E ET AL.: "Incidence of anti hsp 90 and 70 antibodies in children with SLE, juvenile dermatomyositis and juvenile chronic arthritis", CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, vol. 14, no. 1, January 1996 (1996-01-01), pages 99 - 104, XP002097731 *
CRIBB A E ET AL.: "Patients with delayed-onset sulfonamide hypersensitivity reactions have antibodies recognizing endodplasmic reticulum luminal proteins", J.PHARMACOL. EXP. THERAP., vol. 282, no. 2, August 1997 (1997-08-01), pages 1064 - 1071, XP002097729 *
JINDAL S: "Heat shock proteins: applications in health and disease", TRENDS IN BIOTECHNOLOGY, vol. 14, no. 1, January 1996 (1996-01-01), pages 17-20, XP004035805 *
MACARIO A J: "Heat - shock proteins and molecular chaperones: implications for pathogenesis, diagnostics, and therapeutics.", INTERNATIONAL JOURNAL OF CLINICAL AND LABORATORY RESEARCH, (1995) 25 (2) 59-70. REF: 91 JOURNAL CODE: A81. ISSN: 0940-5437., GERMANY: Germany, Federal Republic of, XP002097732 *
TISHLER M ET AL: "Anti- heat - shock protein antibodies in rheumatic and autoimmune diseases.", SEMINARS IN ARTHRITIS AND RHEUMATISM, (1996 OCT) 26 (2) 558-63. REF: 25 JOURNAL CODE: UMV. ISSN: 0049-0172., United States, XP002097730 *

Also Published As

Publication number Publication date
WO1999018131A2 (de) 1999-04-15
DE19744132A1 (de) 1999-04-22
EP1019441A2 (de) 2000-07-19
JP2001519357A (ja) 2001-10-23

Similar Documents

Publication Publication Date Title
WO1997009429A3 (en) Compounds and methods for diagnosis of tuberculosis
WO1998053076A3 (en) Compounds for diagnosis of tuberculosis and methods for their use
NO20005694D0 (no) Spesifikke bindingsmolekyler for scintigrafi, konjugater som inneholder disse og terapeutisk metode for behandling av angiogenese
WO2000052473A3 (en) Radiolabeling kit and binding assay
EE05465B1 (et) Meetod allergeeniga seostuva immunoglobuliini detekteerimiseks proovis, patsiendi allergiate in vitro diagnoosimeetod, mikromaatrikskiip ja komplekt
AU2003280753A1 (en) Kit for assaying human low-molecular weight cd14 and antibody
AU7260496A (en) A method and diagnostic test kit for use in aiding the diagnosis of fibromyyalgia and chronic fatigue syndrome (CFS)
WO1998016645A3 (en) Compounds and methods for diagnosis of tuberculosis
NO821431L (no) Fremgangsmaate og sett for proeving av antilegemer mot antigener
WO1995005604A3 (en) Methods for the diagnosis of alzheimer's disease
WO2001061305A3 (en) Immunoassays detecting or making use of at least two rubber latexallergens
WO2003046140A3 (en) Immunoassay and kit for an early and simulataneous detection of biochemical markers in a patient's sample
WO1992002819A3 (en) Assay for ulcerative colitis and primary sclerosing cholangitis
NO177463C (no) STLV-III-beslektede polypeptider, diagnostiske prövesett og in vitro analysefremgangsmåte for påvisning av anti-HIV-2-antistoffer i kroppsvæskepröve
WO1999018131A3 (de) Anti-bip-antikörper bei rheumatoider arthritis sowie verfahren und testkits zu ihrer bestimmung
CA2213083A1 (en) Detection of antibody production
EP0276984A3 (de) Bestimmung von Anti-DNS-Antikörpern
AU6189486A (en) Monoclonal antibodies to prosomal proteins
CA2202913A1 (en) Antibody reagent for detecting dissecting aortic aneurysm and uses thereof
ATE208040T1 (de) Immunoassay-reagenzien, testsätze und verfahren
AU2002233278A1 (en) Method and use of the cytosolic nadp-dependent malate-decarboxylase isoenzyme for identifying a malignant process, and a suitable test kit
WO2005037228A3 (en) Halogen phosphonate monoesters
WO2002016431A3 (de) PEPTIDE DES α1-ADRENERGEN REZEPTORS UND IHRE VERWENDUNG BEI PSORIASIS
EP1712629A3 (de) Verbindungen und Verfahren zur Diagnose von Tuberkulose
AU8008487A (en) A method for determining the presence of substances of diagnostic relevance, in particular antibodies or antigens, by the ELISA method with photometric evaluation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 09539894

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 1998958806

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1998958806

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1998958806

Country of ref document: EP